Clinical outcome, quality of life, patients’ satisfaction, and aesthetic results, after reduction mammaplasty

2009 ◽  
Vol 43 (4) ◽  
pp. 201-206 ◽  
Author(s):  
Erik Eggert ◽  
Rebecca Schuss ◽  
Åsa Edsander-Nord
Keyword(s):  
Quality Of Life ◽  
Clinical Outcome ◽  
Reduction Mammaplasty ◽  
Outcome Quality ◽  
Patients Satisfaction ◽  
Aesthetic Results

scholarly journals Extradural Motor Cortex Stimulation in Parkinson’s Disease: Long-Term Clinical Outcome

2021 ◽  
Vol 11 (4) ◽  
pp. 416
Author(s):  
Carla Piano ◽  
Francesco Bove ◽  
Delia Mulas ◽  
Enrico Di Stasio ◽  
Alfonso Fasano ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Motor Cortex ◽  
Clinical Outcome ◽  
Motor Cortex Stimulation ◽  
Dopaminergic Therapy

Previous investigations have reported on the motor benefits and safety of chronic extradural motor cortex stimulation (EMCS) for patients with Parkinson’s disease (PD), but studies addressing the long-term clinical outcome are still lacking. In this study, nine consecutive PD patients who underwent EMCS were prospectively recruited, with a mean follow-up time of 5.1 ± 2.5 years. As compared to the preoperatory baseline, the Unified Parkinson’s Disease Rating Scale (UPDRS)-III in the off-medication condition significantly decreased by 13.8% at 12 months, 16.1% at 18 months, 18.4% at 24 months, 21% at 36 months, 15.6% at 60 months, and 8.6% at 72 months. The UPDRS-IV decreased by 30.8% at 12 months, 22.1% at 24 months, 25% at 60 months, and 36.5% at 72 months. Dopaminergic therapy showed a progressive reduction, significant at 60 months (11.8%). Quality of life improved by 18.0% at 12 months, and 22.4% at 60 months. No surgical complication, cognitive or behavioral change occurred. The only adverse event reported was an infection of the implantable pulse generator pocket. Even in the long-term follow-up, EMCS was shown to be a safe and effective treatment option in PD patients, resulting in improvements in motor symptoms and quality of life, and reductions in motor complications and dopaminergic therapy.

Psychological factors influencing motivation, cooperation, participation, satisfaction, self appraisal, and individual quality of life in adolescents and adults undergoing Orthodontic treatment

2021 ◽  
Vol 11 (1) ◽  
pp. 34-39
Author(s):  
Oshin Pawar ◽  
Purva Joneja ◽  
Deepak Singh Choudhary
Keyword(s):  
Quality Of Life ◽  
Psychological Factors ◽  
Orthodontic Treatment ◽  
The Self ◽  
Main Concern ◽  
Individual Quality ◽  
Patients Satisfaction ◽  
Before And After ◽  
Individual Quality Of Life

Introduction: To bring the best outcome from both the sides i.e. the orthodontist and the patient , it is of prime importance to understand certain psychological factors, and to treat every patient with an individualistic approach. The need was to study all such psychological factors and to find a method to deal with the same; to evaluate the psychological factors that influences the self appraisal and individual Quality of life. To compare psychological factor affecting the self appraisal and individual quality of life before treatment and after treatment, to study psychological factors of patients which influences the treatment outcome and to find a method to manage them. Materials and Method: This In-vivo study, includes case study and survey. Two separate sets of questionnaires (before and after undergoing orthodontic treatment) were given to patients. The study also included psychological test scales like OHIP-14 and 12-CSES. The sample size of patient was 150. Result: The study revealed that esthetics (95%) is the main concern for getting treatment especially for female (56%). There is improvement in OHIP and CSES (interval of 12.63, 14.66) score of patients before and after treatment. Patients’ satisfaction (94.7%) increases on having healthy orthodontist-patient relationship. Conclusion: Esthetics is the main concern. Most patients wants improvement in smile. Lack of awareness and lack of financial supports is the main reason for delay in getting treatment. The main discomfort about the treatment reported by participants was pain after activation appointments, ulcers and change in food eating habit. The orthodontic therapy improves confidence, satisfaction, individuals’ appraisal and quality of life. There were no variations in response for patients’ satisfaction by gender, age, education or by treatment duration.

Quality of Life of Patients Suffering from Schizophrenia Treated with Clozapine and Risperidone

2009 ◽  
Vol 24 (S1) ◽  
pp. 1-1
Author(s):  
M. Milosavljevic ◽  
D. Lecic-Tosevski ◽  
I. Perunicic
Keyword(s):  
Quality Of Life ◽  
Clinical Outcome ◽  
Social Relationships ◽  
Atypical Antipsychotics ◽  
Clinical Status ◽  
Positive Symptoms ◽  
Significant Difference ◽  
Social Recovery ◽  
Improve Clinical Outcome

Background:Quality of life (QoL) is considered an important outcome in the treatment of schizophrenia and is linked with clinical and social recovery. Until recently treatments of schizophrenia have focused mainly on reducing positive symptoms, often leaving patients with numerous residual difficulties. It's been expected that atypical antipsychotics improve QoL equally as they improve clinical outcome of the patients with schizophrenia.Objectives:To compare clinical improvement and QoL of patients treated with risperidone and clozapine two months after the beginning of treatment.Methods:The sample included 40 patients (17 males and 23 females, mean age 33.1) with diagnosis of schizophrenia according to ICD-X. the patients were treated with either risperidone (n=20) or clozapine (n=20). the PANSS and CGI scales for clinical status were applied at the beginning of the treatment and two months later. the QoL was assessed by the WHOQOL-BREF.Results:Analysis of data has shown a significant difference for all four domains (physical, psychological, social relationships and environment) at WHOQOL-BREF scale for both medications after two months, but no difference between the two antipsychotics. the patients treated with clozapine had significantly higher scores on PANSS at the beginning of treatment. PANSS and CGI applied after two months have not shown differences between the medications.Conclusion:Both clozapine and risperidone had equal and statistically significant effect in reducing the symptoms of schizophrenia measured by PANSS and CGI in two months period, as well as in improving the quality of life. However no difference was found between the two medications.

Sign in / Sign up

Export Citation Format

Share Document